Human Blood Culture

A key issue for Healthcare professionals is the need for diagnostic systems capable of detecting life threatening diseases such as septicaemia in the minimum time.

Considerable advantages have been identified in “near patient” testing, however, because of limited product offerings suitable for near-patient use, exacerbated by reducing budgets and a diminishing numbers of trained microbiologists the trend is toward increasingly centralised testing in large laboratories.

This movement towards centralised testing is at total odds to the demands of the healthcare industry. On the contrary to these trends in current practices, the demand is actually for rapid testing at the point of care. This is simply not feasible with existing machines for both logistical and economic reasons.

Uniquely, Bactest is the first company in Human Blood Culture to address these true customer requirements and seemingly complex financial, technical, and logistical issues associated with providing the highest quality care in the most efficient manner.

CYTOMAIA has been specifically designed using state of the art materials and solutions to address a comprehensive list of requirements and benefits demanded by professional Clinicians and Microbiologists alike.

Bactest was formed with the objective of developing a new generation of automated blood culture machines from first principles using advanced state of the art components which would be capable of responding to the very real needs of the global healthcare market.

Human Healthcare


Bactest has created a wholely owned subsidiary to exploit proprietory platform technologies in the Human Health Sector.

Read More
Contact Us